DataStream Content Solutions (DSCS) offered data conversion and enrichment services for a broad segment of government and business entities. DSCS was acquired by the Dolan Company in December 2010 for $20.5 million.

Digene developed the first gene-based test for human papillomavirus (HPV). The company’s test screened for the presence of high-risk types of the virus shown to be the cause of cervical cancer. The company was acquired by Qiagen NV in 2007 for $1.6 billion.

InventWood develops high-performance, cost-effective, and carbon-sequestering SuperWood and cellulose materials to replace unsustainable alternatives that are widely used today. The company’s lead product, SuperWood, is stronger and lighter than steel. InventWood is opening a 90,000-square-foot production facility slated to produce 1,000,000 square feet of boards and veneers annually.

Ion Storage Systems develops solid-state batteries that are safer, lighter, and enable form factors with tighter packing density that enhance system performance. The company recently commissioned one of the largest solid-state battery manufacturing facilities in the U.S., in Beltsville, Md.

Martek Biosciences developed and commercialized life’s DHA, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed. At one point, Martek supplied DHA to infant formula companies representing 75 percent of the worldwide and nearly 100 percent of the U.S. retail markets. More than 200 domestic and international companies launched non-infant formula products containing Martek’s DHA product. Martek was acquired by Royal DSM for $1.1 billion in 2010.

Medcura is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical, and consumer market opportunities. The company’s proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications.

NovaScreen Biosciences provided screening, profiling, and assay development services for pharmaceutical and biotechnology companies worldwide, as well as for government agencies such as the National Institutes of Health. The company was acquired by Caliper Life Sciences, Inc. in 2005 for $30 million.

PAICE, a company formed in 1992 to develop hybrid vehicle technology that promoted lower emissions, superior driving performance, and the fuel-efficient operation of internal combustion engines, licensed all 23 of its domestic and foreign patents to Toyota in 2010.  PAICE also licensed its breakthrough 1994 hybrid vehicle patent (U.S. Patent 5,343,970) to Ford Motor Company in 2010, and more automobile manufacturers after.

Pixelligent manufacturers tunable, high refractive index (RI) nanocrystal formulations that enable next-generation electronics, including extended reality devices, OLED and MicroLED displays, and sensor applications. The company’s Baltimore-based 18,000-square-foot, state-of-the-art manufacturing and laboratory facility is supported by sales offices in the Republic of Korea and Taiwan. Pixelligent has acquired $88 million in funding and has 44 employees.